Literature DB >> 26708152

An overview of potential molecular mechanisms involved in VSMC phenotypic modulation.

Ming-Jie Zhang1, Yi Zhou1, Lei Chen1, Yan-Qin Wang2, Xu Wang1, Yan Pi1, Chang-Yue Gao1, Jing-Cheng Li3, Li-Li Zhang4.   

Abstract

The fully differentiated medial vascular smooth muscle cells (VSMCs) of mature vessels keep quiescent and contractile. However, VSMC can exhibit the plasticity in phenotype switching from a differentiated and contractile phenotype to a dedifferentiated state in response to alterations in local environmental cues, which is called phenotypic modulation or switching. Distinguishing from its differentiated state expressing more smooth muscle (SM)-specific/selective proteins, the phenotypic modulation in VSMC is characterized by an increased rate of proliferation, migration, synthesis of extracellular matrix proteins and decreased expression of SM contractile proteins. Although it has been well demonstrated that phenotypic modulation of VSMC contributes to the occurrence and progression of many proliferative vascular diseases, little is known about the details of the molecular mechanisms of VSMC phenotypic modulation. Growing evidence suggests that variety of molecules including microRNAs, cytokines and biochemical factors, membrane receptors, ion channels, cytoskeleton and extracellular matrix play important roles in controlling VSMC phenotype. The focus of the present review is to provide an overview of potential molecular mechanisms involved in VSMC phenotypic modulation in recent years. To clarify VSMC differentiation and phenotypic modulation mechanisms will contribute to producing cell-based therapeutic interventions for aberrant VSMC differentiation-related diseases.

Entities:  

Keywords:  Ion channels; MicroRNAs; Molecular mechanisms; Phenotypic modulation; Vascular smooth muscle cells

Mesh:

Year:  2015        PMID: 26708152     DOI: 10.1007/s00418-015-1386-3

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  129 in total

1.  alpha 8 Integrin overexpression in de-differentiated vascular smooth muscle cells attenuates migratory activity and restores the characteristics of the differentiated phenotype.

Authors:  Ramin Zargham; Rhian M Touyz; Gaétan Thibault
Journal:  Atherosclerosis       Date:  2007-02-01       Impact factor: 5.162

2.  Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.

Authors:  D Wang; P S Chang; Z Wang; L Sutherland; J A Richardson; E Small; P A Krieg; E N Olson
Journal:  Cell       Date:  2001-06-29       Impact factor: 41.582

Review 3.  The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.

Authors:  R K Assoian; E E Marcantonio
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 4.  G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease.

Authors:  Till F Althoff; Stefan Offermanns
Journal:  J Mol Med (Berl)       Date:  2015-06-14       Impact factor: 4.599

5.  Inhibition of cGMP-dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cells.

Authors:  Nupur B Dey; Kevin F Foley; Thomas M Lincoln; Wolfgang R Dostmann
Journal:  J Cardiovasc Pharmacol       Date:  2005-05       Impact factor: 3.105

6.  MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4.

Authors:  Changqing Xie; Huarong Huang; Xuan Sun; Yanhong Guo; Milton Hamblin; Raquel P Ritchie; Minerva T Garcia-Barrio; Jifeng Zhang; Y Eugene Chen
Journal:  Stem Cells Dev       Date:  2010-10-18       Impact factor: 3.272

7.  Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation.

Authors:  Esther Millette; Bernhard H Rauch; Olivier Defawe; Richard D Kenagy; Guenter Daum; Alexander W Clowes
Journal:  Circ Res       Date:  2004-12-29       Impact factor: 17.367

8.  The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.

Authors:  Zhibin Zhou; Jianping Niu; Zhijun Zhang
Journal:  Mol Biol Rep       Date:  2009-09-16       Impact factor: 2.316

9.  Myocardin: a component of a molecular switch for smooth muscle differentiation.

Authors:  Jiyuan Chen; Chad M Kitchen; Jeffrey W Streb; Joseph M Miano
Journal:  J Mol Cell Cardiol       Date:  2002-10       Impact factor: 5.000

10.  Stimulation of calcium entry is prerequisite for DNA synthesis induced by platelet-derived growth factor in vascular smooth muscle cells.

Authors:  H Mogami; I Kojima
Journal:  Biochem Biophys Res Commun       Date:  1993-10-29       Impact factor: 3.575

View more
  26 in total

1.  Downregulating long non-coding RNA PVT1 expression inhibited the viability, migration and phenotypic switch of PDGF-BB-treated human aortic smooth muscle cells via targeting miR-27b-3p.

Authors:  Shouming Li; Xin Zhao; Shaopeng Cheng; Jialiang Li; Xiao Bai; Xiangbin Meng
Journal:  Hum Cell       Date:  2020-10-26       Impact factor: 4.174

2.  Acarbose attenuates migration/proliferation via targeting microRNA-143 in vascular smooth muscle cells under diabetic conditions.

Authors:  Wei-Yuan Chuang; Meng-Hsun Yu; Tsung-Yuan Yang; Kuei-Chuan Chan; Chau-Jong Wang
Journal:  J Food Drug Anal       Date:  2020-09-15       Impact factor: 6.157

3.  Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling.

Authors:  Oli Sarkar; Yuan Li; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

4.  Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles.

Authors:  Leon J Schurgers; Asim C Akbulut; Dawid M Kaczor; Maurice Halder; Rory R Koenen; Rafael Kramann
Journal:  Front Cardiovasc Med       Date:  2018-04-06

5.  Characterization of Carotid Smooth Muscle Cells during Phenotypic Transition.

Authors:  Haize Goikuria; Maria Del Mar Freijo; Reyes Vega Manrique; María Sastre; Elena Elizagaray; Ana Lorenzo; Koen Vandenbroeck; Iraide Alloza
Journal:  Cells       Date:  2018-03-18       Impact factor: 6.600

6.  Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching.

Authors:  Sai Ma; Seyed Mohammad Motevalli; Jiangwei Chen; Meng-Qi Xu; Yabin Wang; Jing Feng; Ya Qiu; Dong Han; Miaomiao Fan; Meiling Ding; Li Fan; Weisheng Guo; Xing-Jie Liang; Feng Cao
Journal:  Theranostics       Date:  2018-06-12       Impact factor: 11.556

7.  Phenotype of Vascular Smooth Muscle Cells (VSMCs) Is Regulated by miR-29b by Targeting Sirtuin 1.

Authors:  Qian-Ru Sun; Xiong Zhang; Kun Fang
Journal:  Med Sci Monit       Date:  2018-09-19

8.  Nucleolin promotes Ang II‑induced phenotypic transformation of vascular smooth muscle cells via interaction with tropoelastin mRNA.

Authors:  Li Fang; Peng-Fei Zhang; Kang-Kai Wang; Zhi-Lin Xiao; Mei Yang; Zai-Xin Yu
Journal:  Int J Mol Med       Date:  2019-02-04       Impact factor: 4.101

9.  Role of PKCδ in Enhanced Expression of Gqα/PLCβ1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats.

Authors:  Mohammed Emehdi Atef; Madhu B Anand-Srivastava
Journal:  PLoS One       Date:  2016-07-05       Impact factor: 3.240

10.  MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling.

Authors:  Jin Pan; Kai Li; Wei Huang; Xiaoqing Zhang
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.